Gonoshasthaya Kendra is scheduled for today to hand over its COVID-19 test kits to Bangabandhu Sheikh Mujib Medical University (BSMMU) for performance trial.
Gonoshasthaya officials met with university official on Saturday and handed over some of their documents.
BSMMU vice-chancellor Kanak Kanti Barua told New Age that they met the Kendra scientists and formed a committee to look after the performance trial procedure.
The committee will decide how many kits they would need for performance trial, he said.
Gonoshasthaya founder Zafrullah said that their team will be meeting with BSMMU formed committee again on Sunday and handover kits for relevant tests.
Gonoshasthaya-RNA Biotech Limited, a concern of Gonoshasthaya Kendra in Bangladesh, developed the kits named Rapid Dot Blot to test COVID-19.
Earlier, Zafrullah complained that Directorate General of Drug Administration was declining to accept kits they developed for detecting COVID-19 infection.
Later on Thursday the Drug Administration allowed the Kendra for performance trial at BSMMU.
US centers for disease control and prevention representative, Bangabandhu Sheikh Mujib Medical University officials were present at the unveiling programme at Gonoshasthaya Kendra Hospital in Dhanmondi of the capital on April 25.
Later, US centers’ country director Michael S Friedman wrote to the Kendra that they were willing to evaluate the kits.
‘We are hopeful of providing them with the kits on Wednesday,’ Zafrullah said.
Want stories like this in your inbox?
Sign up to exclusive daily email
More Stories from Country